Submit Deal

PARSE BIOSCIENCES

Summary

Parse Biosciences offers a new strategy for single cell RNA sequencing that can profile up to 100,000 cells in parallel across up to 48 samples.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 40 M

Avg. Deal Size£ 40 M

Market Context

Senior Management

Sort

Target: PARSE BIOSCIENCES

Bidder: SOLEUS CAPITAL

4 Service Providers

4 Dealmakers

£ 39 M

Value

Target: BIOMAGE

Bidder: PARSE BIOSCIENCES

3 Service Providers

6 Dealmakers

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy